On Wednesday, Shares of Zix Corporation (NASDAQ:ZIXI), gained 4.82% to $5.44.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Zix Corp (ZIXI),DavidsTea Inc (DTEA), ChemoCentryx Inc (CCXI) and Genie Energy Ltd (GNE). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Tuesday, November 17, 2015, the NASDAQ Composite ended at 4,986.02, up 0.03%, the Dow Jones Industrial Average edged 0.04% higher, to finish the day at 17,489.50, and the S&P 500 closed at 2,050.44, down 0.13%.
- Zix Corp’s stock edged lower by 0.38% to close Tuesday’s session at USD 5.19. The company’s shares oscillated between USD 5.15 and USD 5.28. The stock recorded a trading volume of 0.54 million shares, which was above its 50-day daily average volume of 0.39 million shares and above its 52-week average volume of 0.35 million shares. Over the last three days, Zix Corp’s shares have declined by 0.19% and in the past one week it has moved down 2.08%. However, over the last three months, the stock has gained 7.23% and in the past six months, the shares have picked up 12.34%. On a compounded total return basis, the stock yielded a return of 12.10% in the past one month. Further, the company is trading at a price to earnings (TTM) ratio of 57.67 and a price to book (MRQ) ratio of 5.43. This compares to a historical PE ratio of 51.74 and historical PB ratio of 3.65.
- The stock of DavidsTea Inc lost 4.92% to close Tuesday’s session at USD 11.39. The shares of the company moved in the range of USD 10.93 and USD 11.98, marking a new 52-week low during the session. A trading volume of 0.15 million shares was recorded, which was lower than its 150-day daily average volume of 0.20 million shares and below its 52-week average volume of 0.26 million shares. Over the last five days, DavidsTea Inc’s shares have declined by 22.09% and in the past one month, it has lost 28.50%. The company has an Enterprise Value of USD 240.08 million with an EV/Revenue (TTM) ratio of 2.03 and EV/EBITDA (TTM) ratio of 22.64. Further, the stock is trading at a price to sales (TTM) ratio of 2.42 and price to book (MRQ) ratio of 3.30. Additionally, the stock has a Relative Strength Index (RSI) of 52.96.
- Chemo Centryx Inc’s stock raised by 3.10% to close Tuesday’s session at USD 6.66. The company’s shares fluctuated in the range of USD 6.44 and USD 6.80. A total of 0.08 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.20 million shares and was below its 52-week average volume of 0.21 million shares. The company has an Enterprise Value of USD 221.41 million and Market Capitalization of USD 293.92 million with price to book (MRQ) ratio of 3.50. Over the last three days Chemo Centryx Inc’s shares have advanced 4.88% and in the past one week it has moved up 1.52%. However, over the last three months, the stock has lost 5.26% and in the past six months, the shares have shed 13.28%. The stock yielded a negative return 1.91% in the past three months, on a compounded total return basis. Further, the stock has a Relative Strength Index (RSI) of 73.53.
Zix Corporation provides email encryption, data loss prevention (DLP), and Bring-Your-Own-Device solutions to the healthcare, financial services, insurance, and government sectors in the United States.
Shares of PVH Corp (NYSE:PVH), inclined 5.29% to $89.60, during its last trading session.
PVH Corp., declared that it will release its third quarter 2015 earnings results on Wednesday, December 2, 2015 after the market closes. PVH will sponsor a conference call on Thursday, December 3, 2015 at 9:00 A.M. Eastern Standard Time, hosted by Emanuel Chirico, Chairman and Chief Executive Officer, and Michael Shaffer, Executive Vice President and Chief Operating & Financial Officer, to discuss the results.
PVH Corp. operates as an apparel company in the United States and internationally. It designs, markets, and retails men’s and women’s apparel and accessories, branded dress shirts, neckwear, sportswear, jeans wear, intimate apparel, swim products, handbags, footwear, golf apparel, fragrances, cosmetics, eyewear, hosiery, socks, jewelry, watches, outerwear, small leather goods, and home furnishings, in addition to other related products.
Finally, Shares of Wright Medical Group Inc (NASDAQ:WMGI), ended its last trade with 0.92% gain, and closed at $22.05.
Wright Medical Group, declared that TMG Holdings Coöperatief U.A., an associate of Warburg Pincus LLC (the “Selling Shareholder”), intends to offer for sale 4,500,000 of its ordinary shares following the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The Selling Shareholder will receive all of the net proceeds from this offering. No shares are being sold by the Company.
BofA Merrill Lynch is acting as underwriter for the offering.
An automatic shelf registration statement (counting a prospectus) regardingthe offering of ordinary shares was filed with the SEC on November 17, 2015 and became effective upon filing. Before you invest, you should read the prospectus comprised in that registration statement and the documents incorporated by reference in that registration statement, in addition to the prospectus supplement related to this offering. You may obtain these documents for free by visiting EDGAR on the SEC website at www.sec.gov.
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells orthopaedic products in the United States, France, and internationally. The company offers joint implants and bone fixation devices for the shoulder, hand, wrist, elbow, foot, and ankle; sports medicine and biologics products that is used to mechanically repair tissue-to-tissue or tissue-to-bone injuries; and hip and knee joint replacement implants and other ancillary products, counting instrumentation.